Global Strategy & HEOR Consultants

Data-Driven Decisions for
Life Sciences Leaders.

Our multidisciplinary team combines clinical expertise, primary market research, and financial modeling to de-risk your commercial strategy.

Schedule a Consultation Explore Capabilities
Global Network Physician-Led Rapid Turnaround

Our Expertise

Integrated Commercial Strategy

We don't operate in silos. HGL Life brings together HEOR specialists, financial analysts, and market researchers to provide a holistic view of your asset's potential.

Valuation & Forecasting

Decision trees and rNPV models for internal decision-making or licensing deals. We quantify risk and validate revenue assumptions for Phase 1-3 assets.

HEOR & Evidence

Health Economics and Outcomes Research strategies. We undertake Evidence Synthesis, develop Cost-Effectiveness Models and Budget Impact Models to demonstrate value to payers.

Market Access

Navigating the complex landscape of PBMs, payers, and HTAs. We build pricing strategies and value propositions for US, EU5, and APAC markets.

Primary Market Research

We don't guess—we ask. Our team conducts blinded interviews and surveys with KOLs, payers, and physicians to support your strategic decisions.

Commercial Due Diligence

Unbiased, third-party assessment of in-licensing opportunities. We stress-test the commercial claims of potential partners before you invest.

New Product Planning

We specialize in Opportunity Assessment, Target Product Profile (TPP) testing, and Market Fit Assessment to ensure your asset addresses unmet needs.

We bridge the gap between Clinical Science and Commercial Reality.

Leadership & Team

A Convergence of Clinical, Technical & Commercial Minds.

HGL Life is not a generalist consultancy. We are a specialized collective of medical doctors, engineers, HEOR scientists, and biopharma strategists.

Led by Dr. Hari Thrivikramji (MBBS, MBA, MSc Finance, MSc Health Economics) in the US and Marina George (BEng Electronics Engineering and MSc Health Data Analytics) in the UK, our leadership team brings four decades of global experience from the life sciences industry.

Global Reach

Operations in US, UK & India.

Boutique Agility

Direct access to senior partners.

The HGL Advantage

Collective Experience 40+ Years across Big Pharma
Data Source
Primary Research Proprietary Databases
Focus Areas
Oncology Hematology Cardiology Immunology Neurology Gene Therapy Rare Disease

"We help clients speak the languages of the clinic, the boardroom, and the payer simultaneously."

HGL Life team - diverse life sciences consulting professionals collaborating on pharmaceutical strategy

Built for the Modern Life Sciences Firm

Collaborative Execution

Our team integrates with your internal staff. We don't just hand over a PDF and leave; we partner with you through the decision-making process.

Evidence-Based Consulting

Whether it's strategy development or decision modeling or HEOR modeling, our work is grounded in rigorous data analysis and verified by real-world primary research.

AI-Integrated Workflows

We use AI across our work to ensure that our work utilises cutting edge technology to benefit our clients with speed and precision.

Thought Leadership

Insights & Industry Perspectives

View All Episodes
BLOG
Article

How Educated Politicians Can Make a Difference in Our Country

Exploring the impact of education and leadership in shaping policy and governance.

Read Article
VIDEO
Video

Education and Skill Building for Indians

Insights on developing skills and education pathways for growth and opportunity.

Watch Video
VIDEO
Video

Isometric Exercises That Have the Potential to Lower Blood Pressure

Learn about effective isometric exercises and their cardiovascular benefits.

Watch Video
Accepting New Partners

Let's Model Your Success.

Discuss your specific needs in Commercial Strategy or Market Access. Our team is ready to deploy rapid assessments to de-risk your next big decision.

Global Operations

US, UK & India

Stay Informed

Subscribe to our newsletter for the latest insights in life sciences strategy and market access.